China Universal Asset Management Company’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,000
Closed -$846K 503
2026
Q1
$889K Buy
+16,000
New +$867K 0.07% 207
2025
Q4
Sell
-6,000
Closed -$280K 492
2025
Q3
$259K Buy
6,000
+5,662
+1,675% +$221K 0.02% 311
2025
Q2
$13.1K Hold
338
﹤0.01% 462
2025
Q1
$13.2K Hold
338
﹤0.01% 469
2024
Q4
$32.2K Sell
338
-54,007
-99% -$1.94M ﹤0.01% 472
2024
Q3
$2.24M Hold
54,345
0.25% 88
2024
Q2
$2.11M Hold
54,345
0.3% 66
2024
Q1
$2.35M Hold
54,345
0.3% 73
2023
Q4
$2.03M Buy
+54,345
New +$1.95M 0.4% 67

Other funds holding GSK

China Universal Asset Management Company's GSK Position: Q2 2026 in Review

China Universal Asset Management Company sold out of GSK (GSK) in Q2 2026, closing a stake of 16,000 shares — an estimated $846K sold.

China Universal Asset Management Company first reported a position in GSK in Q4 2023 and held it in 9 quarters. The position peaked at $2.35M in Q1 2024. 751 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • China Universal Asset Management Company reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • China Universal Asset Management Company sold 16,000 GSK shares in Q2 2026, an estimated $846K.
  • China Universal Asset Management Company first reported a position in GSK in Q4 2023 and held it in 9 quarters.
  • China Universal Asset Management Company's GSK position peaked at $2.35M in Q1 2024.
  • 751 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.